世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

アジア太平洋地域のTSM（検査、スクリーニング、モニタリング）機器の市場展望、2028年


Asia-Pacific TSM (Testing, Screening & Monitoring) Devices Market Outlook, 2028

アジア太平洋地域は人口が多く、多様性に富んでいる。人口の多さに加え、人口動態の変化や高齢化が進んでいる国もあるため、検査、スクリーニング、モニタリング機器などのヘルスケア・サービスの市場が大きく成... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Bonafide Research & Marketing Pvt. Ltd.
ボナファイドリサーチ 		2023年11月30日 US$3,450
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		88 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

アジア太平洋地域は人口が多く、多様性に富んでいる。人口の多さに加え、人口動態の変化や高齢化が進んでいる国もあるため、検査、スクリーニング、モニタリング機器などのヘルスケア・サービスの市場が大きく成長している。アジア太平洋地域では、糖尿病、心血管疾患、呼吸器疾患などの慢性疾患の有病率が上昇傾向にある。このような慢性疾患の負担の増大が、これらの疾患の早期発見、継続的モニタリング、効果的管理を可能にするTSM機器に対する需要を促進している。アジア太平洋地域の多くの国々は経済成長を経験しており、医療費の増加につながっている。可処分所得の増加に伴い、個人や医療機関はTSM機器を含む先進医療技術への投資をより積極的に行うようになっている。アジア太平洋地域のいくつかの国では、政府の取り組みや投資を通じて医療インフラの強化に力を入れている。これには、医療施設の近代化、医療サービスへのアクセス改善、TSM機器を含む革新的医療技術の導入促進への取り組みが含まれる。アジア太平洋地域の人々の間では、予防医療と疾病の早期発見の重要性に対する認識が高まっている。このような意識が、個人が積極的に健康状態をモニターし、予防措置を講じる力を与えるTSM機器に対する需要を促進している。COVID-19パンデミックのような最近の世界的な健康事象は、流行に備えるための効果的な検査、スクリーニング、モニタリングの重要性を強調している。この認識により、公衆衛生上の緊急事態に対応する地域の能力を高めるため、医療インフラとTSM機器への投資が増加している。アジア太平洋地域における都市化と生活様式の変化は、非伝染性疾患のリスク増大と関連している。継続的なモニタリングと早期介入を可能にするTSM機器は、都市化とライフスタイルの変化に伴う健康上の課題に対処する上で極めて重要である。

Bonafide Research社の調査レポート「アジア太平洋地域の検査、スクリーニング、モニタリング（TSM）市場の展望、2028年」によると、同市場は2023年から28年までに年平均成長率9％で成長すると予測されている。アジア太平洋地域では、遠隔患者モニタリング（RPM）機器の採用が増加しています。RPMは医療提供者が遠隔で患者を監視することを可能にし、特に農村部の人口が多い国では有益である。この傾向は、慢性疾患の有病率の増加と継続的な患者ケアの必要性によって支えられている。健康モニタリング機能を備えたスマートウォッチやフィットネストラッカーなどのウェアラブルデバイスが人気を集めている。これらのデバイスは、消費者に様々な健康指標を追跡する機能を提供し、セルフモニタリングと積極的な健康管理の文化を醸成している。人工知能（AI）と機械学習は、特に診断目的のTSMデバイスでますます活用されるようになっている。これらの技術は、診断の精度を高め、画像解析をサポートし、複雑なデータセットの解釈において医療専門家を支援する。TSM機器と統合されたものも含め、モバイルヘルスアプリケーションはますます普及している。これらのアプリケーションは、健康モニタリング、服薬アドヒアランス、患者と医療従事者間のコミュニケーションを促進し、医療管理の改善に貢献する。アジア太平洋地域のいくつかの国では、農村部における医療格差への対応が重要な焦点となっています。TSMデバイス、特に遠隔モニタリングや診断をサポートするデバイスは、遠隔地や十分なサービスを受けていない地域の人々の医療アクセスを改善する上で重要な役割を果たします。アジア太平洋地域の一部の都市では、スマートシティ構想とTSM機器の統合を模索している。これには、公衆衛生サービス、都市計画、緊急対応システムの強化のために、健康モニタリング・デバイスからのデータを活用することが含まれる。

市場は中国、日本、インド、オーストラリア、韓国に分類される。中国では、急速な経済発展、医療投資の増加、中産階級の人口急増により、TSM機器市場が活況を呈している。中国政府は医療インフラの近代化に取り組んでおり、革新的な技術に注力していることもあって、先進的なTSM機器の導入が進んでいる。特に、中国市場ではウェアラブル・ヘルス技術、遠隔患者モニタリング・ソリューション、AIを活用した診断が急増している。中国では人口が多く高齢化が進んでいるため、特に慢性疾患管理のための継続的な健康モニタリングに対する需要が高まっており、TSM技術の拡大に適した土壌が形成されている。同様にインドでも、TSM機器市場はさまざまな要因によって大きな成長を遂げている。国民皆保険の実現に向けたインドの取り組みは、慢性疾患の有病率の増加と相まって、TSMソリューションの需要を牽引している。同国では、ポイント・オブ・ケア検査、遠隔医療の導入、予防医療への注目が高まっている。デジタルヘルスを推進するインド政府の取り組みと、医療システムへのTSM機器の統合が、市場の拡大に寄与している。さらに、インド市場には革新的な技術を活用するヘルスケア新興企業の強固なエコシステムがあり、TSMの展望をさらに多様化している。

製品別では、市場は血糖モニター、心拍モニター、多項目患者監視装置、薬物アルコールスクリーニング検査、ECG装置、その他に分類される。アジア太平洋地域では、薬物乱用や中毒関連の問題が増加している。政府や組織は、これらの懸念に対処するための効果的なスクリーニングやモニタリングツールの必要性を認識するようになっており、薬物スクリーニング装置の需要を牽引している。アジア太平洋地域の多くの企業は、職場の安全を重視し、薬物のない職場環境を確保するために薬物スクリーニング・プログラムを実施している。このため、職業環境における薬物スクリーニング装置の需要が高まっている。多くの組織は、従業員スクリーニング・プログラムの一環として、雇用前および定期的な薬物スクリーニングを実施している。公共部門と民間部門の両方でこのようなプログラムが実施されているため、薬物スクリーニング装置の需要が高まっています。薬物スクリーニングは、患者の安全性と効果的な治療のために薬物乱用の監視が重要である医療やリハビリテーションの現場でも不可欠です。医療業界は患者の幸福とコンプライアンスに重点を置いているため、薬物スクリーニング装置の需要に拍車をかけている。航空やロジスティクスを含む運輸業界では、しばしば厳しい安全規制があり、安全が重視される職務に携わる従業員の薬物スクリーニングが義務付けられています。これらの規制の遵守は、薬物スクリーニング装置の需要に大きく貢献している。学校や大学などの教育機関は、安全で薬物のない学習環境を維持するために、学生や職員に対して薬物スクリーニング・プログラムを実施することがあります。これにより、薬物スクリーニング装置の用途は職場以外にも広がっています。

エンドユーザーに基づき、市場は病院、家庭、その他に分類される。アジア太平洋地域では、糖尿病や心血管疾患などの慢性疾患の有病率が増加している。個人が自分の健康をモニターする便利な方法を求めるにつれて、家庭用検査、スクリーニング、モニター装置の需要が高まっている。アジア太平洋地域では人口の高齢化が進み、加齢に伴う慢性疾患の発生率が高くなっている。高齢者は利便性から在宅モニタリングソリューションを好むことが多く、TSM機器市場における在宅セグメントの成長に寄与している。意識の高まりと消費者中心の医療へのシフトにより、個人が健康管理に積極的な役割を果たすようになった。家庭用検査機器は、医療機関を頻繁に訪れることなく健康パラメータをモニターする能力をユーザーに提供する。アジア太平洋地域の都市部では多忙なライフスタイルのため、定期的な検査のために医療機関を訪れることは困難である。家庭用検査機器は、日常生活を中断することなく健康状態をモニターするための便利で時間節約になるソリューションを提供する。適応症の観点から、市場は心血管障害・高血圧、糖尿病、妊娠、呼吸器疾患、がん、運動障害、聴覚障害、創傷ケア、その他の適応症（睡眠障害、腎臓障害、神経血管疾患、HIV）に区分される。女性が高齢出産を選択し、出産が遅れる傾向が観察されている。母体の高年齢化は特定のリスクと関連しており、妊娠中の早期かつ定期的なモニタリングが不可欠となっている。この傾向は、妊娠関連検査機器の需要に寄与している。アジア太平洋地域では、妊娠糖尿病、子癇前症など、さまざまな妊娠関連合併症が発生している。モニタリング機器は、これらの合併症の早期発見と管理において重要な役割を果たし、市場の成長に寄与している。

本レポートの対象企業

Abbott Laboratories, Koninklijke Philips N.V., 日本光電工業株式会社, Siemens Healthineers, Mindray Medical International Limited, Medline Industries LP, Baxter International Inc, GE HealthCare Technologies, Inc, Omron Corporation, Beurer GmbH, Drägerwerk AG & Co.KGaA、テレダイン・テクノロジーズ・インコーポレーテッド

本レポートで検討している企業

- 地域アジア太平洋地域
- 歴史的な年2017
- 基準年2022
- 推定年2023
- 予測年2028

本レポートでカバーされている側面

- アジア太平洋地域の検査、スクリーニング、モニタリング（TSM）市場の展望とその価値およびセグメント別の予測
- 国別の検査、スクリーニング、モニタリング（TSM）市場分析
- 様々な促進要因と課題
- 進行中のトレンドと開発
- 注目企業
- 戦略的提言

レポート対象国

- 中国
- 日本
- インド
- オーストラリア
- 韓国

製品別

- 血糖値モニター
- 心拍数モニター
- マルチパラメータ患者モニタリング
- 薬物スクリーニング
- 心電計（ECG）
- その他（血圧モニター、パルスオキシメーター、体温モニター、胎児モニター、その他）

エンドユーザー別

- 病院
- ホーム
- その他

適応症別

- 心血管疾患・高血圧
- 糖尿病
- 妊娠
- 呼吸器疾患
- 癌
- 運動障害
- 聴覚障害
- 創傷ケア
- その他の適応症

レポートのアプローチ

本レポートは、一次調査と二次調査を組み合わせたアプローチで構成されている。当初は、市場を理解し、そこに存在する企業をリストアップするために二次調査が用いられた。二次調査は、プレスリリース、企業の年次報告書、政府が作成した報告書やデータベースなどの第三者情報源からなる。二次情報源からデータを収集した後、一次調査は、市場がどのように機能しているかについて主要プレーヤーに電話インタビューを行い、市場のディーラーや流通業者と取引コールを行うことによって実施した。その後、消費者を地域別、階層別、年齢層別、性別に均等にセグメンテーションし、一次調査を開始した。一次データが揃えば、二次ソースから得た詳細の検証を開始することができる。

対象読者

本レポートは、検査・スクリーニング・モニタリング（TSM）産業に関連する業界コンサルタント、メーカー、サプライヤー、団体、組織、政府機関、その他のステークホルダーが市場中心の戦略を調整する際に役立ちます。マーケティングやプレゼンテーションに加え、業界に関する競合知識を高めることもできます。




***注：ご注文確認後、レポートのお届けまで48時間（2営業日）かかります。

ページTOPに戻る


目次

Table of Contents
1. Executive Summary
2. Research Methodology
2.1. Secondary Research
2.2. Primary Data Collection
2.3. Market Formation & Validation
2.4. Report Writing, Quality Check & Delivery
3. Market Structure
3.1. Market Considerate
3.2. Assumptions
3.3. Limitations
3.4. Abbreviations
3.5. Sources
3.6. Definitions
4. Economic /Demographic Snapshot
5. Global Testing, Screening and Monitoring (TSM) Devices Market Outlook
5.1. Market Size By Value
5.2. Market Share By Region
5.3. Market Size and Forecast, By Product
5.4. Market Size and Forecast, By End User
5.5. Market Size and Forecast, By Indication
6. Asia-Pacific Testing, Screening and Monitoring (TSM) Devices Market Outlook
6.1. Market Size By Value
6.2. Market Share By Country
6.3. Market Size and Forecast, By Product
6.4. Market Size and Forecast, By End User
6.5. Market Size and Forecast, By Indication
7. Market Dynamics
7.1. Market Drivers & Opportunities
7.2. Market Restraints & Challenges
7.3. Market Trends
7.4. Covid-19 Effect
7.5. Supply chain Analysis
7.6. Policy & Regulatory Framework
7.7. Industry Experts Views
7.8. China Testing, Screening and Monitoring (TSM) Devices Market Outlook
7.8.1. Market Size By Value
7.8.2. Market Size and Forecast By Product
7.8.3. Market Size and Forecast By End User
7.8.4. Market Size and Forecast By Indication
7.9. Japan Testing, Screening and Monitoring (TSM) Devices Market Outlook
7.9.1. Market Size By Value
7.9.2. Market Size and Forecast By Product
7.9.3. Market Size and Forecast By End User
7.9.4. Market Size and Forecast By Indication
7.10. India Testing, Screening and Monitoring (TSM) Devices Market Outlook
7.10.1. Market Size By Value
7.10.2. Market Size and Forecast By Product
7.10.3. Market Size and Forecast By End User
7.10.4. Market Size and Forecast By Indication
7.11. Australia Testing, Screening and Monitoring (TSM) Devices Market Outlook
7.11.1. Market Size By Value
7.11.2. Market Size and Forecast By Product
7.11.3. Market Size and Forecast By End User
7.11.4. Market Size and Forecast By Indication
7.12. South Korea Testing, Screening and Monitoring (TSM) Devices Market Outlook
7.12.1. Market Size By Value
7.12.2. Market Size and Forecast By Product
7.12.3. Market Size and Forecast By End User
7.12.4. Market Size and Forecast By Indication
8. Competitive Landscape
8.1. Competitive Dashboard
8.2. Business Strategies Adopted by Key Players
8.3. Key Players Market Positioning Matrix
8.4. Porter's Five Forces
8.5. Company Profile
8.5.1. Abbott Laboratories
8.5.1.1. Company Snapshot
8.5.1.2. Company Overview
8.5.1.3. Financial Highlights
8.5.1.4. Geographic Insights
8.5.1.5. Business Segment & Performance
8.5.1.6. Product Portfolio
8.5.1.7. Key Executives
8.5.1.8. Strategic Moves & Developments
8.5.2. Koninklijke Philips N.V.
8.5.3. Nihon Kohden Corporation
8.5.4. Siemens Healthineers
8.5.5. Mindray Medical International Limited
8.5.6. Medline Industries LP
8.5.7. Baxter International Inc.
8.5.8. GE HealthCare Technologies, Inc.
8.5.9. Omron Corporation
8.5.10. Beurer GmbH
8.5.11. Drägerwerk AG & Co. KGaA
8.5.12. Teledyne Technologies Incorporated
9. Strategic Recommendations
10. Annexure
10.1. FAQ`s
10.2. Notes
10.3. Related Reports
11. Disclaimer

List of Figures
Figure 1: Global Testing, Screening and Monitoring (TSM) Devices Market Size (USD Billion) By Region, 2022 & 2028
Figure 2: Market attractiveness Index, By Region 2028
Figure 3: Market attractiveness Index, By Segment 2028
Figure 4: Global Testing, Screening and Monitoring (TSM) Devices Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 5: Global Testing, Screening and Monitoring (TSM) Devices Market Share By Region (2022)
Figure 6: Asia-Pacific Testing, Screening and Monitoring (TSM) Devices Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 7: Asia-Pacific Testing, Screening and Monitoring (TSM) Devices Market Share By Country (2022)
Figure 8: China Testing, Screening and Monitoring (TSM) Devices Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 9: Japan Testing, Screening and Monitoring (TSM) Devices Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 10: India Testing, Screening and Monitoring (TSM) Devices Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 11: Australia Testing, Screening and Monitoring (TSM) Devices Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 12: South Korea Testing, Screening and Monitoring (TSM) Devices Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 13: Competitive Dashboard of top 5 players, 2022
Figure 14: Porter's Five Forces of Global Testing, Screening and Monitoring (TSM) Devices Market

List of Table
Table 1 : Global Testing, Screening and Monitoring (TSM) Devices Market Snapshot, By Segmentation (2022 & 2028) (in USD Billion)
Table 2: Top 10 Counties Economic Snapshot 2020
Table 3: Economic Snapshot of Other Prominent Countries 2020
Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 5 : Global Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast, By Product (2017 to 2028F) (In USD Billion)
Table 6 : Global Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 7 : Global Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)
Table 8 : Asia-Pacific Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast, By Product (2017 to 2028F) (In USD Billion)
Table 9 : Asia-Pacific Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 10 : Asia-Pacific Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)
Table 11 : Influencing Factors for Testing, Screening and Monitoring (TSM) Devices Market, 2022
Table 12 : Chiina Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 13 : Chiina Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 14 : Chiina Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 15 : Japan Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 16 : Japan Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 17 : Japan Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 18 : India Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 19 : India Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 20 : India Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 21 : Australia Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 22 : Australia Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 23 : Australia Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 24 : South Korea Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 25 : South Korea Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 26 : South Korea Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)

　

ページTOPに戻る


　

Summary

The Asia Pacific region is home to a large and diverse population. The sheer size of the population, coupled with changing demographics and an aging population in some countries creates a substantial market for healthcare services, including testing, screening, and monitoring devices. The prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and respiratory conditions, is on the rise in the Asia Pacific region. This growing burden of chronic illnesses is driving the demand for TSM devices that enable early detection, continuous monitoring, and effective management of these conditions. Many countries in the Asia Pacific region are experiencing economic growth, leading to increased healthcare expenditure. As disposable incomes rise, individuals and healthcare institutions are more willing and able to invest in advanced healthcare technologies, including TSM devices. Several countries in the Asia Pacific region are focusing on strengthening their healthcare infrastructure through government initiatives and investments. This includes efforts to modernize healthcare facilities, improve access to medical services, and promote the adoption of innovative medical technologies, including TSM devices. There is a growing awareness of the importance of preventive healthcare and early detection of diseases in the Asia Pacific population. This awareness is driving the demand for TSM devices that empower individuals to monitor their health proactively and take preventive measures. Recent global health events, such as the COVID-19 pandemic, have underscored the importance of effective testing, screening, and monitoring for epidemic preparedness. This realization has led to increased investments in healthcare infrastructure and TSM devices to enhance the region's ability to respond to public health emergencies. Urbanization and changes in lifestyle patterns in the Asia Pacific region are associated with an increased risk of non-communicable diseases. TSM devices that enable continuous monitoring and early intervention are crucial in addressing the health challenges associated with urbanization and lifestyle changes.

According to the research report, "Asia Pacific Testing, Screening, and Monitoring (TSM) Market Outlook, 2028," published by Bonafide Research, the market is anticipated to grow at a 9% CAGR by 2023–28. The adoption of Remote Patient Monitoring (RPM) devices is increasing across the Asia Pacific region. RPM allows healthcare providers to monitor patients remotely, particularly beneficial in countries with large rural populations. This trend is supported by the growing prevalence of chronic diseases and the need for continuous patient care. Wearable devices, such as smartwatches and fitness trackers equipped with health monitoring features, are gaining popularity. These devices offer consumers the ability to track various health metrics, fostering a culture of self-monitoring and proactive health management. Artificial Intelligence (AI) and machine learning are being increasingly utilized in TSM Devices, particularly for diagnostic purposes. These technologies enhance the accuracy of diagnostics, support image analysis, and assist healthcare professionals in interpreting complex data sets. Mobile health applications, including those integrated with TSM Devices, are becoming increasingly popular. These applications facilitate health monitoring, medication adherence, and communication between patients and healthcare providers, contributing to improved healthcare management. Addressing healthcare disparities in rural areas is a key focus in several Asia Pacific countries. TSM Devices, especially those that support remote monitoring and diagnostics, play a crucial role in improving healthcare access for populations in remote or underserved regions. Some cities in the Asia Pacific region are exploring the integration of TSM Devices with smart city initiatives. This involves leveraging data from health monitoring devices to enhance public health services, urban planning, and emergency response systems.

The market is categorized into China, Japan, India, Australia and South Korea. In China, the TSM Devices market is thriving due to the country's rapid economic development, increasing healthcare investments, and a burgeoning middle-class population. The Chinese government's commitment to modernizing healthcare infrastructure, coupled with a focus on innovative technologies, has propelled the adoption of advanced TSM Devices. Notably, the market in China is witnessing a surge in wearable health technology, remote patient monitoring solutions, and AI-powered diagnostics. The large and aging population in China is driving demand for continuous health monitoring, especially for chronic disease management, creating a fertile ground for the expansion of TSM technologies. Similarly, in India, the TSM Devices market is experiencing significant growth fuelled by a combination of factors. India's commitment to achieving universal healthcare access, coupled with an increasing prevalence of chronic diseases, is driving the demand for TSM solutions. The country is witnessing a rise in point-of-care testing, telehealth adoption, and a focus on preventive healthcare. The Indian government's initiatives to promote digital health and the integration of TSM Devices in healthcare systems are contributing to the market's expansion. Additionally, the Indian market showcases a robust ecosystem of healthcare startups leveraging innovative technologies, further diversifying the TSM landscape.

In terms of product the market is categorized into Blood Glucose Monitor, Heart Rate Monitors, Multi Parameter Patient Monitoring Device, Drug Alcohol Screening Testing, ECG Devices and others. The Asia Pacific region has witnessed an increase in drug abuse and addiction-related issues. Governments and organizations are increasingly recognizing the need for effective screening and monitoring tools to address these concerns, driving the demand for drug screening devices. Many companies in the Asia Pacific region are emphasizing workplace safety and implementing drug screening programs to ensure a drug-free work environment. This has led to a growing demand for drug screening devices in occupational settings. Many organizations conduct pre-employment and periodic drug screening as part of their employee screening programs. The implementation of such programs, both in the public and private sectors, fuels the demand for drug screening devices. Drug screening is also vital in healthcare and rehabilitation settings, where monitoring for substance abuse is crucial for patient safety and effective treatment. The healthcare industry's focus on patient well-being and compliance adds to the demand for drug screening devices. The transportation industry, including aviation and logistics, often has strict safety regulations that mandate drug screening for employees involved in safety-sensitive roles. Compliance with these regulations contributes significantly to the demand for drug screening devices. Educational institutions, including schools and universities, may implement drug screening programs for students and staff to maintain a safe and drug-free learning environment. This extends the application of drug screening devices beyond workplaces.

Based on end user the market is categorized into Hospitals, Home and others. The Asia Pacific region has witnessed an increase in the prevalence of chronic diseases, such as diabetes and cardiovascular conditions. As individuals seek convenient ways to monitor their health, there is a growing demand for home testing, screening, and monitoring devices. The aging population in the Asia Pacific region has led to a higher incidence of age-related chronic conditions. Older individuals often prefer home-based monitoring solutions for their convenience, contributing to the growth of the Home segment in the TSM Devices market. Increasing awareness and a shift towards consumer-centric healthcare have empowered individuals to take an active role in managing their health. Home testing devices provide users with the ability to monitor their health parameters without the need for frequent visits to healthcare facilities. Busy lifestyles in urban areas of the Asia Pacific region make it challenging for individuals to visit healthcare facilities for routine testing. Home testing devices offer a convenient and time-saving solution for monitoring health conditions without disrupting daily routines. In terms of indications the market is segmented into Cardiovascular Disorders & Hypertension, Diabetes, Pregnancy, Respiratory Diseases, Cancer, Movement Disorders, Hearing Disorders, Wound Care and Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV). A trend of delayed childbirth, with women choosing to have children at older ages, has been observed. Advanced maternal age is associated with certain risks, making early and regular monitoring during pregnancy essential. This trend contributes to the demand for pregnancy-related testing devices. The Asia Pacific region experiences various pregnancy-related complications, including gestational diabetes, preeclampsia, and other conditions. Monitoring devices play a crucial role in the early detection and management of these complications, contributing to the growth of the market.

Companies covered in this report:

Abbott Laboratories , Koninklijke Philips N.V., Nihon Kohden Corporation, Siemens Healthineers, Mindray Medical International Limited, Medline Industries LP, Baxter International Inc., GE HealthCare Technologies, Inc., Omron Corporation, Beurer GmbH, Drägerwerk AG & Co. KGaA, Teledyne Technologies Incorporated

Considered in this report

• Geography: Asia Pacific
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report

• Asia pacific Testing, Screening, and Monitoring (TSM) market Outlook with its value and forecast along with its segments
• Country-wise Testing, Screening, and Monitoring (TSM) market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• China
• Japan
• India
• Australia
• South Korea

By Product:

• Blood Glucose Monitor
• Heart Rate Monitors
• Multiparameter Patient Monitoring
• Drug Screening
• Electrocardiograph (ECG)
• Others (Blood Pressure Monitoring Devices, Pulse Oximeter, Patient Temperature Monitoring, Fetal Monitoring Devices, Others)

By End User:

• Hospitals
• Home
• Others

By Indication:

• Cardiovascular Disorders & Hypertension
• Diabetes
• Pregnancy
• Respiratory Diseases
• Cancer
• Movement Disorders
• Hearing Disorders
• Wound Care
• Other Indications

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Testing, Screening, and Monitoring (TSM) industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.




***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.



ページTOPに戻る


Table of Contents

Table of Contents
1. Executive Summary
2. Research Methodology
2.1. Secondary Research
2.2. Primary Data Collection
2.3. Market Formation & Validation
2.4. Report Writing, Quality Check & Delivery
3. Market Structure
3.1. Market Considerate
3.2. Assumptions
3.3. Limitations
3.4. Abbreviations
3.5. Sources
3.6. Definitions
4. Economic /Demographic Snapshot
5. Global Testing, Screening and Monitoring (TSM) Devices Market Outlook
5.1. Market Size By Value
5.2. Market Share By Region
5.3. Market Size and Forecast, By Product
5.4. Market Size and Forecast, By End User
5.5. Market Size and Forecast, By Indication
6. Asia-Pacific Testing, Screening and Monitoring (TSM) Devices Market Outlook
6.1. Market Size By Value
6.2. Market Share By Country
6.3. Market Size and Forecast, By Product
6.4. Market Size and Forecast, By End User
6.5. Market Size and Forecast, By Indication
7. Market Dynamics
7.1. Market Drivers & Opportunities
7.2. Market Restraints & Challenges
7.3. Market Trends
7.4. Covid-19 Effect
7.5. Supply chain Analysis
7.6. Policy & Regulatory Framework
7.7. Industry Experts Views
7.8. China Testing, Screening and Monitoring (TSM) Devices Market Outlook
7.8.1. Market Size By Value
7.8.2. Market Size and Forecast By Product
7.8.3. Market Size and Forecast By End User
7.8.4. Market Size and Forecast By Indication
7.9. Japan Testing, Screening and Monitoring (TSM) Devices Market Outlook
7.9.1. Market Size By Value
7.9.2. Market Size and Forecast By Product
7.9.3. Market Size and Forecast By End User
7.9.4. Market Size and Forecast By Indication
7.10. India Testing, Screening and Monitoring (TSM) Devices Market Outlook
7.10.1. Market Size By Value
7.10.2. Market Size and Forecast By Product
7.10.3. Market Size and Forecast By End User
7.10.4. Market Size and Forecast By Indication
7.11. Australia Testing, Screening and Monitoring (TSM) Devices Market Outlook
7.11.1. Market Size By Value
7.11.2. Market Size and Forecast By Product
7.11.3. Market Size and Forecast By End User
7.11.4. Market Size and Forecast By Indication
7.12. South Korea Testing, Screening and Monitoring (TSM) Devices Market Outlook
7.12.1. Market Size By Value
7.12.2. Market Size and Forecast By Product
7.12.3. Market Size and Forecast By End User
7.12.4. Market Size and Forecast By Indication
8. Competitive Landscape
8.1. Competitive Dashboard
8.2. Business Strategies Adopted by Key Players
8.3. Key Players Market Positioning Matrix
8.4. Porter's Five Forces
8.5. Company Profile
8.5.1. Abbott Laboratories
8.5.1.1. Company Snapshot
8.5.1.2. Company Overview
8.5.1.3. Financial Highlights
8.5.1.4. Geographic Insights
8.5.1.5. Business Segment & Performance
8.5.1.6. Product Portfolio
8.5.1.7. Key Executives
8.5.1.8. Strategic Moves & Developments
8.5.2. Koninklijke Philips N.V.
8.5.3. Nihon Kohden Corporation
8.5.4. Siemens Healthineers
8.5.5. Mindray Medical International Limited
8.5.6. Medline Industries LP
8.5.7. Baxter International Inc.
8.5.8. GE HealthCare Technologies, Inc.
8.5.9. Omron Corporation
8.5.10. Beurer GmbH
8.5.11. Drägerwerk AG & Co. KGaA
8.5.12. Teledyne Technologies Incorporated
9. Strategic Recommendations
10. Annexure
10.1. FAQ`s
10.2. Notes
10.3. Related Reports
11. Disclaimer

List of Figures
Figure 1: Global Testing, Screening and Monitoring (TSM) Devices Market Size (USD Billion) By Region, 2022 & 2028
Figure 2: Market attractiveness Index, By Region 2028
Figure 3: Market attractiveness Index, By Segment 2028
Figure 4: Global Testing, Screening and Monitoring (TSM) Devices Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 5: Global Testing, Screening and Monitoring (TSM) Devices Market Share By Region (2022)
Figure 6: Asia-Pacific Testing, Screening and Monitoring (TSM) Devices Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 7: Asia-Pacific Testing, Screening and Monitoring (TSM) Devices Market Share By Country (2022)
Figure 8: China Testing, Screening and Monitoring (TSM) Devices Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 9: Japan Testing, Screening and Monitoring (TSM) Devices Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 10: India Testing, Screening and Monitoring (TSM) Devices Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 11: Australia Testing, Screening and Monitoring (TSM) Devices Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 12: South Korea Testing, Screening and Monitoring (TSM) Devices Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 13: Competitive Dashboard of top 5 players, 2022
Figure 14: Porter's Five Forces of Global Testing, Screening and Monitoring (TSM) Devices Market

List of Table
Table 1 : Global Testing, Screening and Monitoring (TSM) Devices Market Snapshot, By Segmentation (2022 & 2028) (in USD Billion)
Table 2: Top 10 Counties Economic Snapshot 2020
Table 3: Economic Snapshot of Other Prominent Countries 2020
Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 5 : Global Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast, By Product (2017 to 2028F) (In USD Billion)
Table 6 : Global Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 7 : Global Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)
Table 8 : Asia-Pacific Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast, By Product (2017 to 2028F) (In USD Billion)
Table 9 : Asia-Pacific Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 10 : Asia-Pacific Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)
Table 11 : Influencing Factors for Testing, Screening and Monitoring (TSM) Devices Market, 2022
Table 12 : Chiina Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 13 : Chiina Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 14 : Chiina Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 15 : Japan Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 16 : Japan Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 17 : Japan Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 18 : India Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 19 : India Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 20 : India Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 21 : Australia Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 22 : Australia Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 23 : Australia Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 24 : South Korea Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Product (2017 to 2028F) (In USD Billion)
Table 25 : South Korea Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 26 : South Korea Testing, Screening and Monitoring (TSM) Devices Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（環境・エネルギー）の最新刊レポート

Bonafide Research & Marketing Pvt. Ltd.社のLifescience 分野での最新刊レポート

本レポートと同じKEY WORD（devices）の最新刊レポート


よくあるご質問


Bonafide Research & Marketing Pvt. Ltd.社はどのような調査会社ですか?


Bonafide Research & Marketing Pvt. Ltd.は、最新の経済、人口統計、貿易、市場データを提供する市場調査・コンサルティング会社です。調査レポート、カスタムレポート、コ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/23　10:26

157.72 円

164.94 円

201.11 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.